Stuart A. Arbuckle

Vertex Pharmaceuticals

EVP & Chief Commercial Officer

Overview

Stuart A. Arbuckle made an average of $7.8M in compensation at Vertex Pharmaceuticals from 2012 to 2016.

Annual data

2016

In 2016, Stuart A. Arbuckle earned a total compensation of $5.6M as EVP & Chief Commercial Officer at Vertex Pharmaceuticals.

Ranking1,342 out of 13,853
Percentile90.3%

Stuart A. Arbuckle's 2016 compensation ranked 1,342nd out of 13,853 executive pay records tracked by us this year.

Arbuckle earned more than 90.3% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking78 out of 1,472
Percentile94.7%

In the industry group of Drugs, Arbuckle's pay ranked 78th out of 1,472 executive pay records tracked by us in 2016.

Arbuckle earned more than 94.7% of executives in this group.

Non-Equity Incentive Plan$420,000
Option Awards$1,305,144
Salary$672,885
Stock Awards$3,150,148
Other$12,885
Total$5,561,062

Arbuckle received $3.2M in stock awards, which accounts for 56.65% of total compensation.

Arbuckle also received $420K in non-equity incentive plan, $1.3M in option awards, $672.9K in salary and $12.9K in other compensation.

2015

In 2015, Stuart A. Arbuckle earned a total compensation of $8.8M as EVP & Chief Commercial Officer at Vertex Pharmaceuticals.

Ranking653 out of 13,574
Percentile95.2%

Stuart A. Arbuckle's 2015 compensation ranked 653rd out of 13,574 executive pay records tracked by us this year.

Arbuckle earned more than 95.2% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking61 out of 1,484
Percentile95.9%

In the industry group of Drugs, Arbuckle's pay ranked 61st out of 1,484 executive pay records tracked by us in 2015.

Arbuckle earned more than 95.9% of executives in this group.

Non-Equity Incentive Plan$721,500
Option Awards$5,199,586
Salary$629,262
Stock Awards$2,258,991
Other$13,110
Total$8,822,449

Arbuckle received $5.2M in option awards, which accounts for 58.94% of total compensation.

Arbuckle also received $721.5K in non-equity incentive plan, $629.3K in salary, $2.3M in stock awards and $13.1K in other compensation.

2014

In 2014, Stuart A. Arbuckle earned a total compensation of $15.2M as EVP & Chief Commercial Officer at Vertex Pharmaceuticals.

Ranking223 out of 12,876
Percentile98.3%

Stuart A. Arbuckle's 2014 compensation ranked 223rd out of 12,876 executive pay records tracked by us this year.

Arbuckle earned more than 98.3% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking26 out of 1,310
Percentile98.0%

In the industry group of Drugs, Arbuckle's pay ranked 26th out of 1,310 executive pay records tracked by us in 2014.

Arbuckle earned more than 98.0% of executives in this group.

Non-Equity Incentive Plan$675,000
Option Awards$4,044,646
Salary$600,000
Stock Awards$9,865,110
Other$12,857
Total$15,197,613

Arbuckle received $9.9M in stock awards, which accounts for 64.91% of total compensation.

Arbuckle also received $675K in non-equity incentive plan, $4M in option awards, $600K in salary and $12.9K in other compensation.

2013

In 2013, Stuart A. Arbuckle earned a total compensation of $4.8M as EVP & Chief Commercial Officer at Vertex Pharmaceuticals.

Ranking1,331 out of 11,965
Percentile88.9%

Stuart A. Arbuckle's 2013 compensation ranked 1,331st out of 11,965 executive pay records tracked by us this year.

Arbuckle earned more than 88.9% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking77 out of 1,095
Percentile93.0%

In the industry group of Drugs, Arbuckle's pay ranked 77th out of 1,095 executive pay records tracked by us in 2013.

Arbuckle earned more than 93.0% of executives in this group.

Non-Equity Incentive Plan$630,000
Option Awards$3,077,513
Salary$553,846
Stock Awards$544,988
Other$12,675
Total$4,819,022

Arbuckle received $3.1M in option awards, which accounts for 63.86% of total compensation.

Arbuckle also received $630K in non-equity incentive plan, $553.8K in salary, $545K in stock awards and $12.7K in other compensation.

2012

In 2012, Stuart A. Arbuckle earned a total compensation of $4.8M as EVP & Chief Commercial Officer at Vertex Pharmaceuticals.

Ranking1,264 out of 10,949
Percentile88.5%

Stuart A. Arbuckle's 2012 compensation ranked 1,264th out of 10,949 executive pay records tracked by us this year.

Arbuckle earned more than 88.5% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking58 out of 850
Percentile93.2%

In the industry group of Drugs, Arbuckle's pay ranked 58th out of 850 executive pay records tracked by us in 2012.

Arbuckle earned more than 93.2% of executives in this group.

Bonus$365,000
Non-Equity Incentive Plan$117,600
Option Awards$1,731,692
Salary$169,615
Stock Awards$2,131,308
Other$293,482
Total$4,808,697

Arbuckle received $2.1M in stock awards, which accounts for 44.32% of total compensation.

Arbuckle also received $365K in bonus, $117.6K in non-equity incentive plan, $1.7M in option awards, $169.6K in salary and $293.5K in other compensation.